Strategies for converting turn-motif and cyclic peptides to small molecules for targeting protein–protein interactions

Abstract

Peptides are great starting points for drug discovery, but challenges remain in converting that potential to approved drugs. We review strategies for moving peptide features to small molecules, enabling small molecule drug development expertise.